Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 54 publications
Tailoring disease-modifying therapy approaches across multiple sclerosis sub-populations.
Journal: Multiple sclerosis and related disorders
Published: May 01, 2026
Early Versus Delayed Treatment with Ocrelizumab: A Multicenter, Real-World Observational Study in People with Multiple Sclerosis.
Journal: Neurology and therapy
Published: December 16, 2025
Comparative Effectiveness and Risk of Severe Infection in Adult Patients With MS Treated With Diroximel Fumarate Versus Anti-CD20 Monoclonal Antibodies: A Real-World Claims Analysis.
Journal: Advances in therapy
Published: October 23, 2025
Long-term follow-up of patients with multiple sclerosis over age 60: Comparing clinical and radiological outcomes in disease-modifying therapy continuers and discontinuers.
Journal: Multiple sclerosis journal - experimental, translational and clinical
Published: October 20, 2025
Assessing Progression Independent of Relapse Activity in Multiple Sclerosis Using a Patient-Reported Disability Measure and Self-Administered Neuroperformance Outcomes.
Journal: Annals of neurology
Published: September 01, 2025
Switch from intravenous anti-CD20 therapy to subcutaneous ofatumumab in patients with relapsing MS: results from the OLIKOS study.
Journal: Journal of neurology
Published: July 30, 2025
Outcomes of older patients with multiple sclerosis treated with interferon beta-1a or peginterferon beta-1a in MS PATHS.
Journal: Neurodegenerative disease management
Published: July 15, 2025
Advancing multiple sclerosis management in older adults.
Journal: Nature reviews. Neurology
Published: June 16, 2025
Real World Effectiveness and Tolerability of Novel Monoclonal Antibodies and Rituximab for NMOSD.
Journal: Annals of clinical and translational neurology
Published: April 09, 2025
De-escalation of disease modifying therapies: A retrospective, observational single center study.
Journal: Multiple sclerosis and related disorders
Published: December 24, 2024
Impact of Age on Switching or Stopping Disease Modifying Therapies in Multiple Sclerosis.
Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
Published: December 08, 2024
Last Updated: 09/26/2026